A detailed history of Black Rock Inc. transactions in Lexaria Bioscience Corp. stock. As of the latest transaction made, Black Rock Inc. holds 27,445 shares of LEXX stock, worth $59,006. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27,445
Previous 1,508 1719.96%
Holding current value
$59,006
Previous $5,000 1420.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$1.99 - $4.0 $51,614 - $103,748
25,937 Added 1719.96%
27,445 $76,000
Q1 2024

May 10, 2024

BUY
$1.29 - $6.25 $1,945 - $9,425
1,508 New
1,508 $5,000

Others Institutions Holding LEXX

About Lexaria Bioscience Corp.


  • Ticker LEXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,951,000
  • Market Cap $12.8M
  • Description
  • Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. The company's DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x ...
More about LEXX
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.